Study Evaluating GAP-486 in Heart Rhythm

Stopped early · Phase 2

Conditions studied: Arrhythmia

In brief

The purpose of this study is to learn the effects of a test drug on heart rhythm, and to provide additional data to see if the test drug is well tolerated and safe.

Key facts

Study ID

NCT00137293

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

30

Starts

2005-11-01

Expected to finish

2006-10-01

Last updated by the study team

2007-12-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing an electrophysiology study for evaluation of heart rhythm.

You may not qualify if…

• Patients with uncontrolled blood pressure
• Patients with certain cardiac risk factors
• Patients with significant kidney or liver problems

Where it is running

• Study site — San Francisco, California, United States
• Study site — Washington D.C., District of Columbia, United States
• Study site — Hershey, Pennsylvania, United States
• Study site — Ottawa, Ontario, Canada
• Study site — Toronto, Ontario, Canada
• Study site — Montreal, Quebec, Canada
• Study site — Montreal, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.